Canadian drugmaker Valeant Pharmaceuticals has appointed Christina Ackermann as its new general counsel as it comes under scrutiny for its business and accounting practices.
Ackermann (pictured) replaces Robert Chai-Onn as the pharma group’s top lawyer, with the latter set to depart after more than a decade at the company.
Your limit of 1 article in 30 days is up. Please login for full access or subscribe.
Corporate users - click here for simple access (no password needed).
For more information, please contact [email protected]
